Cargando…

Outcomes of Antifungal Prophylaxis in High-Risk Haematological Patients (AML under Intensive Chemotherapy): The SAPHIR Prospective Multicentre Study

Antifungal prophylaxis (AFP) is recommended by international guidelines for patients with acute myeloid leukaemia (AML) undergoing induction chemotherapy and allogeneic hematopoietic cell transplantation. Nonetheless, treatment of breakthrough fungal infections remains challenging. This observationa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gangneux, Jean-Pierre, Padoin, Christophe, Michallet, Mauricette, Saillio, Emeline, Kumichel, Alexandra, Peffault de La Tour, Régis, Ceballos, Patrice, Gastinne, Thomas, Pigneux, Arnaud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712136/ https://www.ncbi.nlm.nih.gov/pubmed/33198192 http://dx.doi.org/10.3390/jof6040281

Ejemplares similares

Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study
por: Gangneux, Jean-Pierre, et al.
Publicado: (2018)

Systemic antifungal strategies in allogeneic hematopoietic stem cell recipients hospitalized in french hematology units: a post-hoc analysis of the cross-sectional observational AFHEM study
por: Michallet, Mauricette, et al.
Publicado: (2022)

Synchronously Amplified Photoacoustic Image Recovery (SAPhIRe)
por: Demissie, Aida A., et al.
Publicado: (2020)

SAPHIR: a Shiny application to analyze tissue section images
por: Germani, Elodie, et al.
Publicado: (2021)

SAPHIRE: Stress and Pulmonary Hypertension in Rheumatoid Evaluation—A Prevalence Study
por: Reeves, G. E. M., et al.
Publicado: (2016)

Incidence of Hospital-Acquired Pneumonia, Bacteraemia and Urinary Tract Infections in Patients with Haematological Malignancies, 2004–2010: A Surveillance-Based Study
por: Huoi, Catherine, et al.
Publicado: (2013)

Genetic polymorphisms at SIRT1 and FOXO1 are associated with carotid atherosclerosis in the SAPHIR cohort
por: Kedenko, Lyudmyla, et al.
Publicado: (2014)

Maintenance of elderly AML patients with androgens
por: Pigneux, Arnaud, et al.
Publicado: (2017)

Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
por: Rafii, Hanadi, et al.
Publicado: (2022)

Antifungal Prophylaxis
por: Johnson, Douglas Clark, et al.
Publicado: (2021)

GABA(A) Receptor-Mediated Sleep-Promoting Effect of Saaz–Saphir Hops Mixture Containing Xanthohumol and Humulone
por: Min, Byungjick, et al.
Publicado: (2021)

Hepatomegaly and fever at the time of neutrophil recovery revealing L-asparaginase toxicity in the treatment of acute lymphoblastic leukemia
por: Saison, Julien, et al.
Publicado: (2014)

Reply: Antifungal Prophylaxis
por: Pennington, Kelly M., et al.
Publicado: (2021)

Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)
por: Mohamed, Aminetou Mint, et al.
Publicado: (2015)

Individualised physical activity programme in patients over 65 years with haematological malignancies (OCAPI): protocol for a single-arm feasibility trial
por: Fournier, Baptiste, et al.
Publicado: (2021)

Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS
por: Chevallier, Patrice, et al.
Publicado: (2016)

Antifungal Prophylaxis in Immunocompromised Patients
por: Vazquez, Lourdes
Publicado: (2016)

Erica Ollmann Saphire: How the Study of HIV and Other Viruses Informed the Rapid Development of Vaccines and Therapeutic Antibodies Against COVID-19
por: Greenspan, Neil S.
Publicado: (2022)

BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study
por: Michallet, Mauricette, et al.
Publicado: (2014)

Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study
por: Lee, Hae-Young, et al.
Publicado: (2014)

Erratum to: BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study
por: Michallet, Mauricette, et al.
Publicado: (2014)

Transplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential Strategies
por: Pan, Hua, et al.
Publicado: (2016)

In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study
por: Devillier, Raynier, et al.
Publicado: (2022)

Antifungal prophylaxis in critically ill patients
por: Silvestri, Luciano, et al.
Publicado: (2008)

Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
por: Vuichard, Danielle, et al.
Publicado: (2014)

Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis
por: Lee, Dong‐Gun, et al.
Publicado: (2019)

Antifungal management in ICU: careful follow-up of voriconazole prescription needed!
por: Reizine, Florian, et al.
Publicado: (2023)

RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT
por: Baron, Frédéric, et al.
Publicado: (2016)

742. Breakthrough Invasive Fungal Infections with Isavuconazonium Sulfate versus Voriconazole as Primary Antifungal Prophylaxis in Patients with Acute Myeloid Leukemia (AML) who Received Induction Chemotherapy
por: Singam, Hareesh v, et al.
Publicado: (2020)

Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients
por: Kurtz, Jean-Emmanuel, et al.
Publicado: (2016)

2212. Cessation of fluoroquinolone prophylaxis in inpatients with haematological malignancy – a retrospective cohort analysis
por: Bapat, Anjaneya, et al.
Publicado: (2023)

Current evidence of antifungal prophylaxis and therapy in pediatric patients
por: Giacchino, Mareva, et al.
Publicado: (2011)

Clinical practice update of antifungal prophylaxis in immunocompromised children
por: Ramos, José Tomás, et al.
Publicado: (2019)

Micafungin as antifungal prophylaxis in non-transplanted haemotological patients
por: Villaescusa, Teresa, et al.
Publicado: (2020)

2737. Real World Evaluation of Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant (aHSCT) Patients, Is Routine Antifungal Prophylaxis Needed?
por: Perreault, Sarah, et al.
Publicado: (2023)

Retrospective and prospective measures of post-traumatic growth reflect different processes: longitudinal evidence of greater decline than growth following a hematopoietic stem-cell transplantation
por: Corman, Maya, et al.
Publicado: (2021)

Mental health and quality of life of patients undergoing hematopoietic stem cell transplantation (HSCT) prior to hospitalization: a cross-sectional complete state health study
por: Corman, Maya, et al.
Publicado: (2021)

The Prospective Effects of Coping Strategies on Mental Health and Resilience at Five Months after HSCT
por: Corman, Maya, et al.
Publicado: (2023)

HAEMATOLOGY IN TROPICAL AREAS: CLINICS IN HAEMATOLOGY
Publicado: (1983)

Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures
por: Cataldo, Maria Adriana, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4evri39s46gsulpm2ed05imffg